Cell Signaling Technology (CST) provides the highest quality antibodies available for use in immunohistochemistry (IHC). CST’s antibodies have been extensively validated by our in-house IHC group in patient samples and clinically relevant mouse models of cancer. Moreover, IHC-validated antibodies from CST demonstrate the exceptional specificity, sensitivity and affinity required for the most accurate results. These novel antibodies provide new insights for basic and clinical researchers and scientists developing new drugs.
Looking for IHC bench tips? Check out Tips for Optimizing IHC Staining on Biocompare.
Antibodies and Kits Validated for Immunohistochemistry
New Products Validated for Immunohistochemistry
|13684||PD-L1 (E1L3N) XP® Rabbit mAb||02/28/2014|
|13508||VAMP2 (D6O1A) Rabbit mAb||02/06/2014|
|12873||SignalSlide® NF-κB p65 IHC Controls||01/30/2014|
|12128||SignalSlide® HER3/ErbB3 IHC Controls||01/27/2014|
|13175||Phospho-PRAS40 (Thr246) (D4D2) XP® Rabbit mAb||01/14/2014|
|13232||T-bet/TBX21 (D6N8B) XP® Rabbit mAb||12/30/2013|
|13333||CD79A (D1X5C) XP® Rabbit mAb||12/30/2013|
|13088||eIF4B (1F5) Mouse mAb||12/23/2013|
|13403||CD9 (D3H4P) Rabbit mAb||12/18/2013|
|13084||Wee1 (D10D2) Rabbit mAb||12/10/2013|